Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: relevant changes with NTBC treatment.
Depetris-Boldini
C
C
Cátedra de Clínica Pediátrica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Hospital de Niños, Argentina.
Galetto
R
R
Videla
M P
MP
de Kremer Dodelson
R
R
D000592:Amino Acid Metabolism, Inborn Errors / Q000188:drug therapy / Q000652:urine*; D002648:Child; D003306:Coproporphyrins / Q000378:metabolism / Q000652:urine*; D003512:Cyclohexanones / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D030342:Genetic Diseases, Inborn; D006801:Humans; D006867:Hydrolases / Q000172:deficiency; D009579:Nitrobenzoates / Q000494:pharmacology*; D014443:Tyrosine / Q000097:blood*
D003306:Coproporphyrins; D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D009579:Nitrobenzoates; D014443:Tyrosine; C031467:coproporphyrin I; D006867:Hydrolases; C020156:fumarylacetoacetase; C077073:nitisinone